NAD+: The Anti-Aging Molecule Your Body Makes Less Of Every Decade
Nicotinamide adenine dinucleotide — NAD+ — sits at the center of cellular energy production, DNA repair, and longevity signaling. It also declines by roughly half between young adulthood and middle age.
NAD+, short for nicotinamide adenine dinucleotide, is not a trendy supplement. It is one of the most fundamental molecules in human biology. It is a coenzyme that every living cell in the body uses to convert food into energy, repair damaged DNA, and regulate the signaling networks that govern aging. It is also a molecule that declines sharply with age — by some estimates, NAD+ levels drop by roughly fifty percent between young adulthood and the age of fifty. That decline is not a rounding error. It has measurable consequences.
What NAD+ Actually Does
NAD+ serves as an electron carrier in the mitochondrial electron transport chain — the cellular machinery that produces ATP, the body’s primary energy currency. Every muscle contraction, every neuron firing, every cellular repair process ultimately depends on ATP, and ATP ultimately depends on NAD+. When NAD+ is abundant, the metabolic engine runs efficiently. When it is depleted, the engine sputters.
DNA Repair and the PARP Pathway
Beyond energy production, NAD+ is the substrate that poly-ADP ribose polymerase enzymes, commonly abbreviated as PARPs, use to repair damaged DNA. Every cell in the body sustains DNA damage constantly — from ultraviolet light, oxidative stress, metabolic byproducts, and random chemistry. PARP enzymes consume NAD+ to perform repairs. When NAD+ is scarce, repair slows, damage accumulates, and cellular dysfunction compounds.
Sirtuins and Longevity Signaling
NAD+ is also required for the activity of sirtuins — a family of enzymes that regulate gene expression, inflammatory response, and cellular senescence. Sirtuins have been implicated in many of the pathways associated with healthy aging, including autophagy and mitochondrial biogenesis. Without adequate NAD+, sirtuins cannot function. This is one of the primary mechanistic arguments for maintaining NAD+ levels as the body ages.
Why NAD+ Declines
The reasons for NAD+ decline are multifactorial. Increased activity of NAD+-consuming enzymes such as CD38 and PARPs, reduced biosynthesis, and changes in cellular redox state all contribute. The decline correlates with many of the hallmarks of aging — fatigue, cognitive slowing, metabolic inflexibility, and reduced exercise tolerance — though correlation is not causation and the full picture remains an active area of research.
Delivery Methods: Injectable, Nasal, and Oral Precursors
NAD+ can be raised through several delivery routes, and they are not equivalent. Injectable NAD+ bypasses the gut entirely and produces the highest peak serum levels, but requires prescription access, sterile compounding, and a willingness to inject. Intranasal delivery offers reasonable bioavailability with less inconvenience. Oral precursors — nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) — are metabolized into NAD+ inside the body, but absorption, first-pass metabolism, and conversion efficiency vary considerably between individuals.
Who Benefits Most
Clinical experience with NAD+ therapy suggests the most pronounced benefits accrue to patients with measurable metabolic dysfunction, chronic fatigue, or accelerated cognitive aging. Younger, healthier patients may notice subtler effects. As with any therapy, the decision to pursue NAD+ should involve a qualified clinician who can evaluate the patient’s full metabolic picture.
Sourcing Considerations
Injectable NAD+ is one of the more difficult compounds to prepare correctly. It is unstable in solution, sensitive to light and temperature, and requires careful formulation to maintain potency through the beyond-use date. A legitimate source is a licensed compounding pharmacy operating under USP 797, with validated stability data and cold-chain distribution. Unregulated online NAD+ is not an acceptable substitute.
The Bottom Line
NAD+ is real biology, not marketing. Its decline with age is well-documented, its role in cellular function is well-characterized, and the case for maintaining it is compelling. The right approach — injection, nasal, or oral precursor — depends on the patient’s goals, budget, and tolerance. The non-negotiable is that any injectable NAD+ must come from a USP 797 compliant pharmacy with verified potency. Everything else is negotiable.
Sources
1. Verdin E — "NAD+ in aging, metabolism, and neurodegeneration" — Science, 2015. pubmed.ncbi.nlm.nih.gov/27304496/
2. Gomes AP et al. — "Declining NAD+ induces a pseudohypoxic state" — Cell, 2013. pubmed.ncbi.nlm.nih.gov/24360282/
3. Covarrubias AJ et al. — "NAD+ metabolism and its roles in cellular processes during ageing" — Nature Reviews MCB, 2021. pmc.ncbi.nlm.nih.gov/articles/PMC7494058/